Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_assertion type Assertion NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_head.
- NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_assertion description "[Simple gene dosage changes are difficult however, to incorporate into this model, in part due to negative feedback loops that govern major cancer mutational targets (e.g., TP53, PTCH, SMAD4) and essentially preclude a haploinsufficient phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_provenance.
- NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_assertion evidence source_evidence_literature NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_provenance.
- NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_assertion SIO_000772 16721048 NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_provenance.
- NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_assertion wasDerivedFrom befree-20150227 NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_provenance.
- NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_assertion wasGeneratedBy ECO_0000203 NP825103.RAPDULj-fvSplhggkB4mLBjDiB7FGdJFe3Ul50m2Rn7gY130_provenance.